Epinephrine Auto-Injector Market Size to Cross over $2 Billion by 2025 – Arizton

The epinephrine auto-injector market is expected to grow at a CAGR of over 8% during the period 2019–2025.

 

The global epinephrine auto-injector market is expected to grow at a steady rate during the forecast period. The growth can be mainly attributed to the growing prevalence of anaphylaxis across demographics. Anaphylaxis is characterized as a potentially threatening systemic allergic reaction. It is most commonly triggered by medication, food allergies, or insect stings.

 

The following factors are likely to contribute to the growth of the epinephrine auto-injector market during the forecast period:

  • Emergence of Innovative Solutions for Anaphylaxis Management
  • Increasing Demand for Generic Epinephrine Auto-injectors at Pharma/Retail Stores
  • Growing Demand for Self-administration of Drugs
  • Availability of Generic Versions of Auto-injectors

 

The study considers the present scenario of the epinephrine auto-injector market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent companies operating in the market.

 

Get your free sample now!

 

Epinephrine Auto-Injector Market – Vendor Profiles

 

Key Vendors

  • Mylan
  • Teva Pharmaceutical Industries
  • Amneal Pharmaceuticals

 Other Vendors

  • Adamis Pharmaceuticals
  • ALK-Abelló
  • Bioprojet PHARMA
  • Bausch & Lomb
  • kaléo
  • Novartis

 

Epinephrine Auto-Injector Market – Segmentation

 

Market Segmentation by Dosage   

  • High
  • Low

Market Segmentation by Age Group 

  • Below 6 Years
  • Between 6 & 12 years
  • Above 12 years

Market Segmentation by End-user   

  • Hospitals & Clinics
  • Individuals
  • Others

Market Segmentation by Geography

  • Europe
    • Spain
    • Germany
    • Netherlands
    • France
    • UK
  • North America
    • US
    • Canada
  • APAC
    • South Korea
    • Japan
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • Turkey
    • Israel
    • South Africa

 

Get your free sample now!

 

Epinephrine Auto-Injector Market – Table of Contents

 

1              Research Methodology

2              Research Objectives

3              Research Process

 

4              Scope & Coverage

4.1          Market Definition

4.1.1      Inclusion

4.1.2      Exclusion

4.2          Base Year

4.3          Scope of The Study

4.4          Market Segments

4.4.1      Market Segmentation by Dosage

4.4.2      Market Segmentation by Age Group

4.4.3      Market Segmentation by End-user

4.4.4      Market Segmentation by Geography

 

5              Report Assumptions & Caveats

5.1          Key Caveats

5.2          Currency Conversion

5.3          Market Derivation

 

6              Market at a Glance

7              Introduction

7.1          Anaphylaxis: Overview

7.1.1      Background

7.1.2      Epinephrine Auto-injectors for the Treatment of Anaphylaxis

7.2          Epinephrine Auto-injectors Market Snapshot

 

8              Market Opportunities & Trends

8.1          Emergence Of Innovative Solutions For Anaphylaxis Management

8.2          Vendors’ Growing Focus On Patient Assistance Programs

8.3          Increasing Demand For Generic Epinephrine Auto-Injectors At Pharma/Retail Stores

 

9              Market Growth Enablers

9.1          Rising Incidence Of Anaphylaxis

9.2          Growing Demand For Self-Administration Of Drugs

9.3          Availability Of Generic Versions Of Auto-Injectors

 

10           Market Restraints

10.1        Presence of Alternative Treatment Options

10.2        Adverse Side Effects Associated With Epinephrine Auto-Injectors

10.3        Shortage of Epinephrine Auto-Injectors

10.4        High Cost of Epinephrine Auto-Injectors

 

11           Market Landscape

11.1        Market Overview

11.2        Market Size & Forecast

11.3        Five Forces Analysis

11.3.1    Threat of New Entrants

11.3.2    Bargaining Power of Suppliers

11.3.3    Bargaining Power of Buyers

11.3.4    Threat of Substitutes

11.3.5    Competitive Rivalry

 

12           Dosage

12.1        Market Snapshot & Growth Engine

12.2        Market Overview

12.3        High Dose

12.3.1    Market Overview

12.3.2    Market Size & Forecast

12.4        Low Dose

12.4.1    Market Overview

12.4.2    Market Size & Forecast

 

13           Age Group

13.1        Market Snapshot & Growth Engine

13.2        Market Overview

13.3        Above 12 Years

13.3.1    Market Overview

13.3.2    Market Size & Forecast

13.4        6-12 Years

13.4.1    Market Overview

13.4.2    Market Size & Forecast

13.5        Below 6 Years

13.5.1    Market Overview

13.5.2    Market Size & Forecast

 

14           End-User

14.1        Market Snapshot & Growth Engine

14.2        Market Overview

14.3        Individuals

14.3.1    Market Overview

14.3.2    Market Size & Forecast

14.4        Hospitals & Clinics

14.4.1    Market Overview

14.4.2    Market Size & Forecast

14.5        Others

14.5.1    Market Overview

14.5.2    Market Size & Forecast

 

15           Geography

15.1        Market Snapshot & Growth Engine

15.2        Geographic Overview

 

16           North America

16.1        Market Overview

16.2        Market Size & Forecast

16.3        North America: Dosage Segmentation

16.3.1    Market Snapshot & Growth Engine

16.4        Key Countries

16.4.1    US: MARKET SIZE & FORECAST

16.4.2    Canada: MARKET SIZE & FORECAST

 

17           Europe

17.1        Market Overview

17.2        Market Size & Forecast

17.3        Europe: Dosage Segmentation

17.3.1    Market Snapshot & Growth Engine

17.4        Key Countries

17.4.1    Germany: Market Size & Forecast

17.4.2    France: Market Size & Forecast

17.4.3    UK: Market Size & Forecast

17.4.4    Spain: Market Size & Forecast

17.4.5    Netherlands: Market Size & Forecast

 

18           APAC

18.1        Market Overview

18.2        Market Size & Forecast

18.3        APAC: Dosage Segmentation

18.3.1    Market Snapshot & Growth Engine

18.4        Key Countries

18.4.1    Japan: Market Size & Forecast

18.4.2    Australia: Market Size & Forecast

18.4.3    South Korea: Market Size & Forecast

 

19           Middle-East & Africa

19.1        Market Overview

19.2        Market Size & Forecast

19.3        Middle-East & Africa: Dosage Segmentation

19.3.1    Market Snapshot & Growth Engine

19.4        Key Countries

19.4.1    Israel: Market Size & Forecast

19.4.2    South Africa: Market Size & Forecast

19.4.3    Turkey: Market Size & Forecast

 

20           Latin America

20.1        Market Overview

20.2        Market Size & Forecast

20.3        Latin America: Dosage Segmentation

20.3.1    Market Snapshot & Growth Engine

20.4        Key Countries

20.4.1    Brazil: Market Size & Forecast

20.4.2    Argentina: Market Size & Forecast

 

Looking for more information? Click Here

 

About Arizton Advisory & Intelligence

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize fool proof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-235-2040/+1 302 469 0707

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/epinephrine-auto-injector-market